India's Dialysis Market Faces High Costs with 3% APAC Share

The dialysis machines sector in India makes up around 3% of the Asia Pacific market, with the majority of machines being imported, leading to increased expenses. GlobalData reported that the market is expected to reach $14 million by 2033 due to the high occurrence and impact of chronic kidney diseases.

Nephro Care India Limited is collaborating with the National Institute of Technology, Silchar to create a prototype of an AI-enabled, remotely monitored machine, with the goal of cutting costs by approximately 75% to about $2,368.5 (INR 200,000), a significant development.

At the same time, Shreya Jain, the medical devices analyst at GlobalData, noted that although haemodialysis machines are more readily available, obstacles in access, cost, and care standards persist.

“Local production support and infrastructure could help manufacturers tailor machines to India’s needs and reduce maintenance expenses, making dialysis more affordable and accessible,” the analyst said.

A large group of patients with end-stage renal disease (ESRD), a major global health issue, need dialysis to filter toxins from their kidneys and maintain a stable life.

The rising prevalence of end-stage renal disease is primarily caused by the growing number of chronic conditions like type 2 diabetes and hypertension. If left untreated, these conditions will result in gradual harm to the kidneys, ultimately resulting in End-Stage Renal Disease (ESRD) if medications are not utilized. Aging individuals are at a higher risk for decreased kidney function and associated complications, making it one of the major factors to consider.